34 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
LN LINE Corporation $41.2 $9.89B N/A
Article Searches
Will Uber Be the Hottest IPO of 2016? http://www.zacks.com/stock/news/226158/will-uber-be-the-hottest-ipo-of-2016?cid=CS-ZC-FT-226158 Aug 01, 2016 - When, and if, Uber goes public, it will be an IPO like never before, and one that draws in the retail investor who is looking to cash in on a household name going public for the first time.
Why is Everyone Copying Snapchat? http://www.zacks.com/stock/news/226689/why-is-everyone-copying-snapchat?cid=CS-ZC-FT-226689 Aug 03, 2016 - On Tuesday, Instagram, the popular photo-sharing app, announced a new feature called "Stories" where users can post photo and video slideshows that disappear after a 24-hour period. This sounds shamelessly familiar to Snapchat Stories. Instagram isn't the only company copying Snapchat's platform, so what is it about Snapchat that makes it so compelling?
As Snapchat IPOs, Its Competition Is Stealing Its Best Ideas http://www.zacks.com/stock/news/251468/as-snapchat-ipos-its-competition-is-stealing-its-best-ideas?cid=CS-ZC-FT-251468 Mar 02, 2017 - Last year, Instagram, the popular photo-sharing app, announced a new feature called "Stories" where users can post photo and video slideshows that disappear after a 24-hour period. If you think that sounds a lot like Snapchat, you'd be correct: it's almost exactly like Snapchat.
3 Reasons Why Facebook (FB) Is Just Getting Started http://www.zacks.com/stock/news/224680/3-reasons-why-facebook-fb-is-just-getting-started?cid=CS-ZC-FT-224680 Jul 22, 2016 - Facebook (FB) has come a long way since its inception in a dorm room at Harvard. With its Q2 Earnings Report right around the corner, let's take a look at why Facebook still has plenty of gas left in the tank.
Better Buy: Twilio Inc vs. Line Corp https://www.fool.com/investing/2017/07/05/better-buy-twilio-inc-vs-line-corp.aspx?source=iedfolrf0000001 Jul 06, 2017 - Will two of the biggest tech IPOs from 2016 finally impress investors this year?
Zacks Friday Finish Line: Does Amazon Prime Day Matter? http://www.zacks.com/stock/news/223692/zacks-friday-finish-line-does-amazon-prime-day-matter?cid=CS-ZC-FT-223692 Jul 15, 2016 - Every Friday afternoon Maddy Johnson and Ryan McQueeny discuss the week's biggest news, and Pokemon GO and Amazon Prime dominated the headlines.
Here's Why Shares of Line Corp. Took a Hit Today https://www.fool.com/investing/2017/04/26/heres-why-shares-of-line-corp-took-a-hit-today.aspx?source=iedfolrf0000001 Apr 26, 2017 - The Japanese messaging company's Q1 sales and earnings jumped -- but perhaps not quite high enough.
Aurinia Pharma's voclosporin shows sustained treatment benefit in LN patients after four years; shares ahead 6% premarket https://seekingalpha.com/news/3253496-aurinia-pharmas-voclosporin-shows-sustained-treatment-benefit-ln-patients-four-years-shares?source=feed_news_all Mar 27, 2017 - Aurinia Pharmaceuticals (NASDAQ:AUPH) perks up 6% premarket on average volume in response to its announcement of positive results from an open-label study, AURION, assessing lead product can
Is Spotify the Next Big IPO Candidate for 2016? http://www.zacks.com/stock/news/223862/is-spotify-the-next-big-ipo-candidate-for-2016?cid=CS-ZC-FT-223862 Jul 18, 2016 - Spotify, the biggest name in streaming music industry, could be poised for a huge debut on the market after its latest $1 billion round of funding. Is the company the next big IPO candidate of the year?
Aurinia's voclosporin shows durable response in mid-stage LN study; shares ahead 5% premarket https://seekingalpha.com/news/3273987-aurinias-voclosporin-shows-durable-response-mid-stage-ln-study-shares-ahead-5-percent?source=feed_news_all Jun 16, 2017 - Aurinia Pharmaceuticals (NASDAQ:AUPH) is up 5% premarket on average volume in response to its announcement of results from its Phase 2b AURA-LV study assessing voclosporin for the treatment

Pages: 1234

Page 1>